Charles Schwab’s Theriva Biologics TOVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-543
| Closed | -$6.36K | – | 3680 |
|
|
2024
Q1 | $6.36K | Hold |
543
| – | – | ﹤0.01% | 3468 |
|
|
2023
Q4 | $5.84K | Hold |
543
| – | – | ﹤0.01% | 3535 |
|
|
2023
Q3 | $7.32K | Hold |
543
| – | – | ﹤0.01% | 3570 |
|
|
2023
Q2 | $13.6K | Hold |
543
| – | – | ﹤0.01% | 3586 |
|
|
2023
Q1 | $9.47K | Hold |
543
| – | – | ﹤0.01% | 3539 |
|
|
2022
Q4 | $6.17K | Hold |
543
| – | – | ﹤0.01% | 3541 |
|
|
2022
Q3 | $14K | Hold |
543
| – | – | ﹤0.01% | 3496 |
|
|
2022
Q2 | $29K | Buy |
+543
| New | +$29K | ﹤0.01% | 3480 |
|
|
2021
Q2 | – | Sell |
-209
| Closed | -$36K | – | 3536 |
|
|
2021
Q1 | $36K | Buy |
+209
| New | +$36K | ﹤0.01% | 3472 |
|
|
2017
Q2 | – | Sell |
-13
| Closed | -$75K | – | 3136 |
|
|
2017
Q1 | $75K | Hold |
13
| – | – | ﹤0.01% | 3029 |
|
|
2016
Q4 | $91K | Hold |
13
| – | – | ﹤0.01% | 3046 |
|
|
2016
Q3 | $204K | Hold |
13
| – | – | ﹤0.01% | 2915 |
|
|
2016
Q2 | $213K | Buy |
+13
| New | +$213K | ﹤0.01% | 2915 |
|